P. ten Dijke

Molecular Biology · 2000–2022

A researcher in the Science corpus: 14 papers; trusts 10 researchers and is trusted by 10 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 132 citations into it; #3,950 of 17,773 by trust here, #2,498 by citations
• Oncology — 64 citations into it; #1,317 of 1,698 by trust here, #867 by citations
• Cancer Research — 36 citations into it
• Genetics — 21 citations into it
• Pathology and Forensic Medicine — 13 citations into it; #317 of 414 by trust here, #149 by citations

Whom P. ten Dijke trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Massagué
2. R. Derynck
3. R. Akhurst
4. G. Blobe
5. Xin-Hua Feng
6. R. Adams
7. Ying E. Zhang
8. Charles J. David
9. S. Teitelbaum

Who trusts P. ten Dijke overall

1. Nikolaos G. Frangogiannis
2. M. Dobaczewski
3. A. Moustakas
4. C. Heldin
5. J. Massagué
6. Mary Y. Wu
7. A. Biernacka
8. C. Hill
9. Bernhard Schmierer
10. L. Vallier

Papers from P. ten Dijke's perspective

Ordered by how strongly the researchers P. ten Dijke trusts endorse each paper. Same corpus, a different order for every researcher.

1. Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors (EMBO Journal)
2. Metastasis: from dissemination to organ-specific colonization (Nature Reviews. Cancer)
3. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. (Molecules and Cells)
4. Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity (Science)
5. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. (Journal of Biological Chemistry)
6. A multigenic program mediating breast cancer metastasis to bone. (Cancer Cell)
7. Bone resorption by osteoclasts. (Science)
8. TGF‐β receptor‐activated p38 MAP kinase mediates Smad‐independent TGF‐β responses
9. Angiogenesis in cancer and other diseases (Nature)
10. SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS

Their papers

• Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors (2002) — 1,195 citations
• Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. (2000) — 923 citations
• Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction (2004) — 697 citations
• Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. (2003) — 749 citations
• New insights into TGF-β–Smad signalling (2004) — 1,170 citations
• Signaling of transforming growth factor‐β family members through Smad proteins (2000) — 536 citations
• Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter* (2002) — 895 citations
• Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist (2004) — 900 citations
• Targeting TGF-β Signaling in Cancer. (2017) — 909 citations
• Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches (2022) — 778 citations
• TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis (2019) — 938 citations
• Extracellular control of TGFβ signalling in vascular development and disease (2007) — 730 citations
• Negative regulation of TGF-β receptor/Smad signal transduction (2007) — 393 citations
• Transforming Growth Factor- 1 to the Bone (2005) — 675 citations